- Home
- AREN vs ESLA Comparison
AREN vs ESLA Comparison
Compare AREN & ESLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AREN | ESLA |
|---|---|---|
| Founded | 2016 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.3M | 69.5M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | AREN | ESLA |
|---|---|---|
| Price | $1.54 | $1.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $8.00 | $8.00 |
| AVG Volume (30 Days) | ★ 78.7K | 28.7K |
| Earning Date | 05-08-2026 | 05-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 191.93 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,892,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 27.46 | N/A |
| 52 Week Low | $1.36 | $0.78 |
| 52 Week High | $7.85 | $3.15 |
Technical Indicators
Market Signals| Indicator | AREN | ESLA |
|---|---|---|
| Relative Strength Index (RSI) | 33.01 | 35.63 |
| Support Level | N/A | $0.97 |
| Resistance Level | $4.47 | $1.35 |
| Average True Range (ATR) | 0.23 | 0.09 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 10.53 | 12.50 |
Price Performance
Historical ComparisonAbout AREN The Arena Group Holdings Inc.
The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The company has four reportable segments: Sports & Leisure, Finance, Lifestyle, and Platform & Other. The company generates revenue from Sports & Leisure. Geographically, the company operates in United States; and Others. It generates maximum revenue from United States.
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.